Navigation Links
SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
Date:9/16/2008

TSX symbol: SBS

CALGARY, Sept. 16 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it is eligible to proceed with its planned Phase I/II human clinical trial of plant-produced insulin now that the 30-day review period of its Investigational New Drug (IND) application has passed. SemBioSys submitted the application in July to the U.S. Food and Drug Administration (FDA), which has now completed its review of the file. As previously announced, SemBioSys intends to conduct the Phase I/II insulin trial in Europe. Prior to proceeding with the planned trial in the United Kingdom, the company's Clinical Trial Application (CTA) must be reviewed by the appropriate European regulatory authorities.

"The company continues to achieve its insulin development milestones on time. Our recent accomplishments confirm our confidence in our regulatory and development strategy using plants as a low-cost production host for insulin. Plant-produced human recombinant insulin represents a major step forward in insulin production. We believe, furthermore, that these upcoming studies could prove to be the greatest achievement in insulin production since the advent of recombinant human insulin in the early 80's," said Andrew Baum, president and chief executive officer of SemBioSys. "The purpose of filing an IND in the U.S., even though we intend to conduct the trial in Europe, is to ensure that we can pursue U.S. and European regulatory approval of our plant-produced insulin contemporaneously. Conducting the planned insulin trial in Europe allows us to establish the bioequivalence of our safflower-produced insulin to commercially available insulin products from both the U.S. and Europe in a single trial."

SemBioSys plans to initiate a Phase I/II human trial of its safflower-produced insulin in the United Kingdom during the f
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys receives milestone payments from AVAC Ltd.
11. SemBioSys announces first quarter 2008 financial and operational results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... It’s a hard truth: Nearly half of ... their post-secondary education are failing to obtain a diploma or ... And according to an analysis by The Resume Place ... uninformed choice of college majors, which leads to underemployment, unemployment ... Some 51.7 percent of post-9/11 veterans using GI Bill ...
(Date:7/28/2014)... , July 28, 2014   The Atlas ... 4-star boutique hotel in the heart of The Atlas Town Center ... Photo - http://photos.prnewswire.com/prnh/20140725/130455 Photo - ... ATLAS , The Atlas ... suites, a sleek restaurant and bar, a wellness spa, a grand ...
(Date:7/26/2014)... 26, 2014 Canada Endoscopy Visualization ... data on the Canada Endoscopy Visualization Systems market. ... dollars, volume (in units) and average prices (in ... Visualization Systems, Mid-Range Endoscopy Visualization Systems and Low-End ... http://www.marketresearchreports.biz/analysis/213254 . , The report also provides ...
(Date:7/25/2014)... CAMBRIDGE, MA -- Trillions of bacteria live in each ... bacteria help digest food and stave off harmful infections, ... understood. , To help shed light on the role ... MIT associate professor Eric Alm recently tracked fluctuations in ... full year. The findings, described in the July 25 ...
Breaking Biology Technology:Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Monitoring the rise and fall of the microbiome 2Monitoring the rise and fall of the microbiome 3
... trend, says that every year and a half the number ... why electronics from smart phones to flat screens, from ... grow ever more varied, powerful, and compact, but also ever ... up against immutable laws of nature, like the finite size ...
... I: High Blood Pressure , aka ... is risky, very expensive, and mostly ineffective.   Fortunately ...   by natural methods that are both effective, inexpensive, and ...   can help reduce   Chronic Heart/Cardiovascular Disease ...
... NuMe Health LLC, a biotechnology company developing evidence-based ... disease status by modifying  the bacteria that live ... formation of its scientific advisory board (SAB). NuMe,s SAB ... the fields of nutrition, diabetes, obesity, health promoting ...
Cached Biology Technology:A SHARP new microscope for the next generation of biochips 2A SHARP new microscope for the next generation of biochips 3A SHARP new microscope for the next generation of biochips 4Drug-Free BLOOD PRESSURE Control & Medical "Take-Away" Treatment are Potential Win-Win Solutions in Health Care 2NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 2NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 3NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 4
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
(Date:7/24/2014)... Scientists at The New York Stem Cell ... to creating a viable cell replacement therapy for ... , For the first time, NYSCF scientists generated ... samples of patients with primary progressive multiple sclerosis ... induce these stem cells into becoming oligodendrocytes, the ...
(Date:7/24/2014)... study has identified two factors that characterize sustainable ... production of highly qualified physics teachers. Specifically, one ... physics teacher education in combination with institutional motivation ... viable. Science, Technology, Engineering and Math (STEM) teacher ... study points the way for institutions seeking to ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Creating sustainable STEM teacher preparation programs 2
... science" breakthrough by Queen,s University researchers into regulating a ... will help prevent heart attacks and strokes. ... the study focuses on the effects of Viagra ... to treat pulmonary hypertension. The team,s findings will ...
... The AACR Molecular Diagnostics in Cancer Therapeutics Development ... and clinical cancer research. This year,s meeting focuses ... To help you take advantage of the meeting,s ... and related abstracts will be available online at: ...
... President Bush today named Robert J. Lefkowitz, M.D., ... Center, a recipient of the National Medal of Science ... being honored for a lifetime of research into understanding ... system that controls the body,s response to drugs and ...
Cached Biology News:Study points to potential new use for Viagra 2AACR hosts Molecular Diagnostics in Cancer Therapeutic Development Meeting 2Duke Medicine physician-scientist receives National Medal of Science 2Duke Medicine physician-scientist receives National Medal of Science 3
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
ASCIZ...
...
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria...
Biology Products: